Mayo collaboration finds source of breast drug s... ( ROCHESTER Minn. -- Mayo Clinic resea...)

Mayo collaboration finds source of breast drug side effect

Date:9/27/2010

ROCHESTER, Minn. -- Mayo Clinic researchers and their international colleagues have discovered genetic variants that lead to severe arthritis for a subset of women when taking aromatase inhibitors to treat their breast cancer. This serious side effect is so painful that many women halt their lifesaving medication. The findings appear today in the online issue of Journal of Clinical Oncology.

"Many women stop taking aromatase inhibitors due to the accompanying joint pain," says James Ingle, M.D., Mayo Clinic oncologist and senior author of the study. "We used the latest genetic technology in a very large group of women and discovered totally new clues to the cause of the main reason women stop this potentially lifesaving drug. Our findings open the door to finding ways to identify women who will develop these side effects and treat those who do, thus allowing more women to take this therapy and decrease their chances of breast cancer recurrence." Aromatase inhibitors are most often used as adjuvant therapy for postmenopausal women with early stage breast cancer.

How the Research Was Conducted

The researchers -- including investigators from the United States, Canada and Japan -- conducted a genome-wide association study to identify gene variants called single nucleotide polymorphisms (SNPs) that are associated with musculoskeletal pain. They selected patients who were enrolled in a prospective clinical trial, MA27, conducted by the NCIC Clinical Trials Group in Canada in collaboration with the NCI-sponsored North American Breast Cancer Groups comparing two aromatase inhibitor drugs. Two controls were matched with each patient and each patient who was selected experienced arthritis-like side effects within the first two years of treatment, or had already dropped out of the trial because of the pain. Researchers studied 293 separate cases, comparing them to 585 controls.

They found four likely SNPs on chromosome 14
'/>"/>

Contact: Robert Nellis
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

1

GOOD

Page: 1 2
Related medicine news :

1. Alexza and Biovail Form Collaboration to Develop and Commercialize AZ-004 (Staccato(R) Loxapine) in North America
2. Web Content Management Enables Government Transparency, Participation, and Collaboration Online
3. MedPage Today(R) and Milwaukee Journal Sentinel Develop Journalism Content Collaboration for Enterprise Medical Reporting
4. NIH-FDA Joint Briefing on Regulatory Science Collaboration
5. International Collaboration: FDA and European Medicines Agency Agree to Accept a Single Orphan Drug Designation Annual Report
6. Carefx Delivers Expert Insights on Health Data Sharing, Collaboration, Quality and Meaningful Use
7. Improved doctor-pharmacist collaboration needed: study
8. Tackling cardiovascular disease surge worldwide requires collaboration
9. French-Based Non-Profit AIDES is Starting a New Collaboration With Goodby, Silverstein & Partners
10. European collaboration seeks to create World Wide Web for robots
11. Johns Hopkins School of Medicine enters collaboration with New York Stem Cell Foundation

Post Your Comments:

(Date:5/22/2013)... 22, 2013 Following the success of ... franchise Fit Body Boot Camp Kincardine has announced ... Meltdown Challenge starting on June 3rd at its ... Durham Street, Kincardine, Ontario. , Fit Body Boot Camp’s ... motivate local community residents to lose a total of ...

(Date:5/22/2013)... NJ (PRWEB) May 22, 2013 ... and management solutions for social enterprise collaboration platforms, ... a consulting firm based in Chicago, Ill. The ... their products and provide best-in-class solutions for SharePoint ... improve collaboration. , AvePoint’s DocAve Software Platform ...

(Date:5/22/2013)... May 22, 2013 Poor adherence to ... not only medical complications and death (some 125,000 deaths ... non-adherence), but increased health-care costs. It’s been estimated that ... are related to poor medication adherence — a reality ... annually. , Indeed, so dire is the degree of ...

(Date:5/22/2013)... 2013 Athletic-Minded Traveler LLC, a ... released today its 2013 U.S. Business Hotel “Fit ... the company’s recommendation after ongoing research of over ... by the editorial staff. Selection criteria included ... court, etc.), in-room workout choices, healthy food offerings, ...

(Date:5/21/2013)... 22, 2013 Swimsuit season is almost here. ... ® products has begun with a 35% discount. , Cellulite ... Many women get the dreaded cellulite even if they are ... skin where they have been stored as toxic lymph and ... easy fixes, a specific program that works to dissolve the ...

Breaking Medicine News(10 mins):Health News:Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 2 Health News:Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 3 Health News:AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration 2 Health News:AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration 3 Health News:Patient Prompt® Announces New Drug Adherence Program to Assist in Prescribed Medication Compliance 2 Health News:2013: The 10 Healthiest Business Hotels in the U.S. 2 Health News:Diminish Cellulite for Swimsuit Season; Sublime Beauty Introduces Cellulite Whisperer® Products in the "Get Ready for Summer Sale" 2

[0] Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity [0] AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration [0] Patient Prompt® Announces New Drug Adherence Program to Assist in Prescribed Medication Compliance [0] 2013: The 10 Healthiest Business Hotels in the U.S.[0] Diminish Cellulite for Swimsuit Season; Sublime Beauty Introduces Cellulite Whisperer® Products in the "Get Ready for Summer Sale"

... to Health Care Management WASHINGTON, May 5 ... and education organization, announced today that Christine G. Leyden, ... Chief Accreditation Officer for URAC has been recognized as ... in Point magazine. Ms. Leyden will be featured ...

... Education Campaign to Share Her Weight-Loss Journey and Inspire Other ... year, actress Caitlin Van Zandt of "Guiding Light" and "The ... the United States,(1) causing her to also be one of ... at risk of heart disease.(2) Caitlin was at risk of ...

... behind on shots when parents don,t make it to ... Scheduling issues, communication problems and a lack of belief ... some of the biggest hurdles to getting parents to ... report. , Missed appointments were linked to children being ...

... Osteosarcoma is the most common and potentially most dangerous ... of 10 - 25. In "Cancer from A to Z" ... dictionary by Dr. Edward Laughlin, learn that before the 1980,s ... be an intimidating place to enter, and the terminology barrier ...

... Demonstrated in Favorable Response Rates and Hearing PreservationSUNNYVALE, ... ARAY ), a global leader in the ... data using the CyberKnife(R) Robotic Radiosurgery System was ... Association of Neurological Surgeons (AANS) Annual Meeting, May ...

... Help Her get a Good Night,s Sleep at the Samaritan ... This week, sons and daughters all over the community will ... woman in their life - Mom. Flowers, cards and ... are lacking is a good night,s sleep."The need for sleep ...

Case in Point Magazine Names URAC Senior Vice President Leader in Health Care Accreditation Video: New Survey Finds 97 Percent of Women Understand Weight Increases Heart Disease Risk - The Leading Cause of Female Death in the United States - Yet 55 Percent Remain Overweight Keeping Appointments Key to Keeping Vaccines on Track 'Cancer from A to Z': A Dictionary of Cancer-Related Terms Presentations at Leading Neurosurgery Meeting Highlight Benefits of CyberKnife Radiosurgery for the Treatment of CNS Indications What does Mom really want for Mothers Day?

(Date:5/22/2013)... FRANCISCO, Calif. , May 22, 2013 ... announced the clinical advancement of three programs in development. ... of a JAK/SYK inhibitor, R348, being developed by Rigel ... two programs are aimed at oncology targets and are ... inhibitor under development by BerGenBio AS (BerGenBio) and a ...

(Date:5/22/2013)... May 22, 2013 WomanCare Global recently ... with an extensive training initiative attended by 90 ... http://photos.prnewswire.com/prnh/20130522/DC18844 ) (Logo: http://photos.prnewswire.com/prnh/20101018/DC83896LOGO ) ... a highly effective subdermal implant composed of two ... levonorgestrel (a synthetic form of the hormone progestin). ...

(Date:5/21/2013)... 2013 NxStage Medical, Inc. (Nasdaq: NXTM ... announced that it has entered into new agreements covering ... to DaVita, the kidney care division of DaVita Healthcare Partners ... For the use of products for home hemodialysis ... has executed a second amended and restated National Service ...

Breaking Medicine Technology:Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 2 Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 3 Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 4 WomanCare Global launches Simplant, Long-acting Reversible Contraception, in Chile 2 NxStage Announces New Agreements with DaVita 2

[0] Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye [0] WomanCare Global launches Simplant, Long-acting Reversible Contraception, in Chile [0] NxStage Announces New Agreements with DaVita

... /PRNewswire-USNewswire/ -- The Barbara,Ann Karmanos Cancer Institute's Philip ... oncology, presented the outcome,of one of the largest ... America and chaired an education session about the,future ... of,Clinical Oncology (ASCO) annual meeting in Chicago, IL. ...

... 2007 - First-in-human results for,IMC-A12, a monoclonal antibody ... to IGF-1R (insulin-like,growth factor type 1 receptor), were ... of Clinical Oncology in Chicago.,The IGF-IR is expressed ... transmits signals that lead to tumor cell growth ...

Cached Medicine Technology:Clinical Trial Results Change Standard of Care for Pancreatic,Cancer Patients, Future Therapies Discussed 2 Clinical Trial Results Change Standard of Care for Pancreatic,Cancer Patients, Future Therapies Discussed 3 Phase I Results for ImClone Pipeline Anti-IGF-1R Monoclonal,Antibody IMC-A12 Presented at ASCO 2 Phase I Results for ImClone Pipeline Anti-IGF-1R Monoclonal,Antibody IMC-A12 Presented at ASCO 3

Clinical Trial Results Change Standard of Care for Pancreatic,Cancer Patients, Future Therapies Discussed Phase I Results for ImClone Pipeline Anti-IGF-1R Monoclonal,Antibody IMC-A12 Presented at ASCO

The Storz Protege is an anterior segment unit only....

The Storz Premiere comes as anterior, posterior and anterior/posterior combo. The combo provides the following modes irrigation, irrigation/aspiration, vitrectomy, and illumination....

Compact ultrasonic phacoemulsification system....

... Precisionist workstation is a unique combination ... allowing infinite flexibility for modular hardware ... the demands of changing cataract surgical ... concept in ophthalmic surgical platforms providing ...

Medicine Products:

Storz Phaco Protige Storz Phaco Premiere Compact Ultrasonic Phacoemulsification System Precisionist Phacoemulsification System